These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31994626)

  • 61. Analysis of the relationship between cancer procoagulant activity and PCNA and Ki-67 expression in cases of common and cellular uterine leiomyomas.
    Szajda SD; Jóźwik M; Sulkowska M; Chabielska E; Sulkowski S; Jóźwik M
    Eur J Gynaecol Oncol; 2006; 27(5):495-9. PubMed ID: 17139986
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Telomere shortening in uterine leiomyomas.
    Bonatz G; Frahm SO; Andreas S; Heidorn K; Jonat W; Parwaresch R
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):591-6. PubMed ID: 9757957
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of 14-3-3 protein family levels and associated receptor expression of estrogen and progesterone in human uterine leiomyomas.
    Wang L; Huang H; Liu D; Fang S; Xian Y; Zhou J; Zuo Y; Wang F; Huang O; He M
    Gynecol Endocrinol; 2012 Aug; 28(8):665-8. PubMed ID: 22329840
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PEP-19 overexpression in human uterine leiomyoma.
    Kanamori T; Takakura K; Mandai M; Kariya M; Fukuhara K; Kusakari T; Momma C; Shime H; Yagi H; Konishi M; Suzuki A; Matsumura N; Nanbu K; Fujita J; Fujii S
    Mol Hum Reprod; 2003 Nov; 9(11):709-17. PubMed ID: 14561813
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
    Bogusiewicz M; Stryjecka-Zimmer M; Postawski K; Jakimiuk AJ; Rechberger T
    Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle.
    Zhou Y; Ren Y; Cui L; Li Z; Zhu Y; Lin W; Wang Y
    Am J Obstet Gynecol; 2014 Nov; 211(5):496.e1-496.e13. PubMed ID: 24909339
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism.
    Sumitani H; Shozu M; Segawa T; Murakami K; Yang HJ; Shimada K; Inoue M
    Endocrinology; 2000 Oct; 141(10):3852-61. PubMed ID: 11014242
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of uterine telocytes and their architecture in leiomyoma.
    Aleksandrovych V; Białas M; Pasternak A; Bereza T; Sajewicz M; Walocha J; Gil K
    Folia Med Cracov; 2018; 58(3):89-102. PubMed ID: 30521514
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I.
    van der Ven LT; Gloudemans T; Roholl PJ; van Buul-Offers SC; Bladergroen BA; Welters MJ; Sussenbach JS; den Otter W
    Int J Cancer; 1994 Nov; 59(3):427-34. PubMed ID: 7927953
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Maintenance of increased Bcl-2 expression in uterine leiomyomas after GnRH agonist therapy.
    Khurana KK; Singh SB; Tatum AH; Schulz V; Badawy SZ
    J Reprod Med; 1999 Jun; 44(6):487-92. PubMed ID: 10394541
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhanced deoxyribonucleic acid damage and repair but unchanged apoptosis in uterine leiomyomas treated with gonadotropin-releasing hormone agonist.
    Huang SC; Chou CY; Lin YS; Tsai YC; Hsu KF; Liu CH; Huang KE
    Am J Obstet Gynecol; 1997 Aug; 177(2):417-24. PubMed ID: 9290461
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling.
    Cesen-Cummings K; Houston KD; Copland JA; Moorman VJ; Walker CL; Davis BJ
    J Soc Gynecol Investig; 2003 Jan; 10(1):11-20. PubMed ID: 12517588
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium.
    Sharara FI; Nieman LK
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):814-9. PubMed ID: 7573249
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
    Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Uterine contractions evaluated on cine MR imaging in patients with uterine leiomyomas.
    Nishino M; Togashi K; Nakai A; Hayakawa K; Kanao S; Iwasaku K; Fujii S
    Eur J Radiol; 2005 Jan; 53(1):142-6. PubMed ID: 15607866
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development and validation of a three-dimensional in vitro model for uterine leiomyoma and patient-matched myometrium.
    Malik M; Catherino WH
    Fertil Steril; 2012 Jun; 97(6):1287-93. PubMed ID: 22425196
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gene and protein expression of progesterone receptor isoforms A and B, p53 and p21 in myometrium and uterine leiomyoma.
    Lora V; Grings AO; Capp E; von Eye Corleta H; Brum IS
    Arch Gynecol Obstet; 2012 Jul; 286(1):119-24. PubMed ID: 22350293
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Type 2 angiotensin II receptor is expressed in human myometrium and uterine leiomyoma and is down-regulated during pregnancy.
    Matsumoto T; Sagawa N; Mukoyama M; Tanaka I; Itoh H; Goto M; Itoh H; Horiuchi M; Dzau VJ; Mori T; Nakao K
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4366-72. PubMed ID: 8954043
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Possible involvement of inflammatory/reparative processes in the development of uterine fibroids.
    Protic O; Toti P; Islam MS; Occhini R; Giannubilo SR; Catherino WH; Cinti S; Petraglia F; Ciavattini A; Castellucci M; Hinz B; Ciarmela P
    Cell Tissue Res; 2016 May; 364(2):415-27. PubMed ID: 26613601
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding.
    Anania CA; Stewart EA; Quade BJ; Hill JA; Nowak RA
    Mol Hum Reprod; 1997 Aug; 3(8):685-91. PubMed ID: 9294852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.